Position in KRYS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$260,508,706
+$260,457,042 QoQ
Shares Held
700,914
+350357.0% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
9.85%
of 13F equity value
Holder Rank
#9
of 422 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VESTOR CAPITAL, LLC holds $261,212,724 across 7 Biotechnology names. KRYS ranks #1 (99.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
This page
|
700,914 | $260,508,706 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
44,835 | $392,530 | |
| 3 | RPRX |
Royalty Pharma plc
|
4,400 | $246,708 | |
| 4 | TWST |
Twist Bioscience Corp
|
413 | $42,489 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
285 | $15,657 | |
| 6 | REPL |
Replimune Group, Inc.
|
557 | $6,165 | |
| 7 | JUNS |
Jupiter Neurosciences, Inc.
|
29 | $469 |
All Filings in KRYS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $260,508,706 | 700,914 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $51,664 | 200 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $42 | 2,940 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||